MSc Drug Discovery with Artificial Intelligence in Liverpool United Kingdom | University of Liverpool

University of Liverpool | Liverpool United Kingdom
Visit institution website for more information
Qualification
Masters Degree (Taught)
Languages
English
Delivery Mode
On-Campus
Tuition (2025)
GBP 14,550
(c. USD19,413.34)
Attendance
Full-time
Full-time Duration
12 months

The Master's program in AI-driven Drug Discovery offers students in-depth expertise and hands-on training in combining drug discovery with artificial intelligence. This curriculum explores key areas such as medicinal chemistry, pharmacology, molecular biology, bioinformatics applications, AI implementation, and pharmaceutical development. Graduates will be prepared for roles in pharmaceutical R&D, whether entering industry directly or pursuing doctoral studies. The program concludes with an industry-partnered research project, offering authentic experience in the interdisciplinary drug discovery process. This AI-focused Drug Discovery degree delivers comprehensive, practice-oriented training for thriving in this evolving field. Instruction comes from two globally renowned departments - Pharmacology & Therapeutics and Chemistry - both ranked among the world's top 40 and honored with the Queen's Prize for excellence in teaching and research. The program employs diverse teaching methods (lectures, tutorials, workshops, collaborative projects, lab work) with an emphasis on active learning throughout.


Destination of Study

Subjects of Study

Language Requirements

English
IELTS

Qualification Requirements

We accept a 2:2 honours degree from a UK university, or an equivalent academic qualification from a similar non-UK institution. This degree should be in a relevant Biology or Chemistry related subject. This includes (but is not restricted to) Pharmacy, Pharmacology, Biotechnology, Material Sciences, Biochemistry, Genetics, Life Sciences, Natural Sciences or Biomedical Sciences.

Tuition GBP 14,550

Similar programs for you